These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38801145)

  • 1. Recrudescence of Sarcoidosis on stopping Hydroxychloroquine pre-contact prophylaxis for COVID-19.
    Ganesan D; Griffiths S; O'Regan A; Breen D; Rutherford RM
    Ir Med J; 2024 May; 117(5):962. PubMed ID: 38801145
    [No Abstract]   [Full Text] [Related]  

  • 2. Pre-Exposure Prophylaxis with Hydroxychloroquine Does Not Prevent COVID-19 nor Virus Related Venous Thromboembolism.
    Perrella A; Orlando V; Trama U; Bernardi FF; Menditto E; Coscioni E
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of hydroxychloroquine for pre-exposure prophylaxis in COVID 19: debate and suggested future course.
    Agarwal M; Ranjan P; Mittal A; Baitha U
    Expert Rev Anti Infect Ther; 2021 Apr; 19(4):413-417. PubMed ID: 32981388
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial.
    Abella BS; Jolkovsky EL; Biney BT; Uspal JE; Hyman MC; Frank I; Hensley SE; Gill S; Vogl DT; Maillard I; Babushok DV; Huang AC; Nasta SD; Walsh JC; Wiletyo EP; Gimotty PA; Milone MC; Amaravadi RK;
    JAMA Intern Med; 2021 Feb; 181(2):195-202. PubMed ID: 33001138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why is pre-exposure prophylaxis with hydroxychloroquine a safe and rationale approach against SARS-CoV-2 infection?
    Mehta S; Bhandari S; Mehta S
    J Glob Antimicrob Resist; 2020 Sep; 22():864-865. PubMed ID: 32777441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of hydroxychloroquine pre-exposure prophylaxis in COVID-19 infection? A case report.
    Kauv J; Lê MP; Veyrier M; Le Hingrat Q; Visseaux B; Massias L; Chauveheid MP; Descamps D; Ghosn J; Peytavin G
    J Antimicrob Chemother; 2020 Sep; 75(9):2706-2707. PubMed ID: 32457980
    [No Abstract]   [Full Text] [Related]  

  • 7. Hydroxychloroquine prophylaxis for COVID-19 contacts in India.
    Rathi S; Ish P; Kalantri A; Kalantri S
    Lancet Infect Dis; 2020 Oct; 20(10):1118-1119. PubMed ID: 32311324
    [No Abstract]   [Full Text] [Related]  

  • 8. Pre-exposure prophylaxis with hydroxychloroquine for high-risk healthcare workers during the COVID-19 pandemic: A structured summary of a study protocol for a multicentre, double-blind randomized controlled trial.
    Grau-Pujol B; Camprubí D; Marti-Soler H; Fernández-Pardos M; Guinovart C; Muñoz J
    Trials; 2020 Jul; 21(1):688. PubMed ID: 32727613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chloroquine or hydroxychloroquine for prophylaxis of COVID-19.
    Principi N; Esposito S
    Lancet Infect Dis; 2020 Oct; 20(10):1118. PubMed ID: 32311322
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection : A Randomized Trial.
    Barnabas RV; Brown ER; Bershteyn A; Stankiewicz Karita HC; Johnston C; Thorpe LE; Kottkamp A; Neuzil KM; Laufer MK; Deming M; Paasche-Orlow MK; Kissinger PJ; Luk A; Paolino K; Landovitz RJ; Hoffman R; Schaafsma TT; Krows ML; Thomas KK; Morrison S; Haugen HS; Kidoguchi L; Wener M; Greninger AL; Huang ML; Jerome KR; Wald A; Celum C; Chu HY; Baeten JM;
    Ann Intern Med; 2021 Mar; 174(3):344-352. PubMed ID: 33284679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloroquine as a prophylactic agent against COVID-19?
    Gendrot M; Javelle E; Clerc A; Savini H; Pradines B
    Int J Antimicrob Agents; 2020 Jun; 55(6):105980. PubMed ID: 32294495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of hydroxychloroquine for COVID-19 prophylaxis: A systematic review and meta-analysis of randomized trials.
    Lewis K; Chaudhuri D; Alshamsi F; Carayannopoulos L; Dearness K; Chagla Z; Alhazzani W;
    PLoS One; 2021; 16(1):e0244778. PubMed ID: 33406138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, Canada.
    Wright JK; Tan DHS; Walmsley SL; Hulme J; O'Connor E; Snider C; Cheng I; Chan AK; Borgundvaag B; McLeod S; Gollob MH; Clarke RJ; Dresser L; Haji F; Mazzulli T; Mubareka S; Jüni P; Lee D; Tomlinson G; Kain KC; Landes M
    Trials; 2020 Jul; 21(1):647. PubMed ID: 32665039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Summary for Patients: Postexposure Hydroxychloroquine Prophylaxis to Prevent SARS-CoV-2 Infection.
    Ann Intern Med; 2021 Mar; 174(3):I16. PubMed ID: 33284685
    [No Abstract]   [Full Text] [Related]  

  • 15. Hydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection.
    Infante M; Ricordi C; Alejandro R; Caprio M; Fabbri A
    Expert Rev Anti Infect Ther; 2021 Jan; 19(1):5-16. PubMed ID: 32693652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial.
    Rajasingham R; Bangdiwala AS; Nicol MR; Skipper CP; Pastick KA; Axelrod ML; Pullen MF; Nascene AA; Williams DA; Engen NW; Okafor EC; Rini BI; Mayer IA; McDonald EG; Lee TC; Li P; MacKenzie LJ; Balko JM; Dunlop SJ; Hullsiek KH; Boulware DR; Lofgren SM;
    Clin Infect Dis; 2021 Jun; 72(11):e835-e843. PubMed ID: 33068425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using time-weighted average change from baseline of SARS-CoV-2 viral load to assess impact of hydroxychloroquine as postexposure prophylaxis and early treatment for COVID-19.
    Kumbhakar R; Neradilek M; Barnabas RV; Stewart J; Stankiewicz Karita HC; Landovitz RJ; Kissinger PJ; Jerome KR; Paasche-Orlow MK; Bershteyn A; Chu HY; Neuzil KM; Greninger AL; Luk A; Wald A; Brown ER; Johnston C
    J Med Virol; 2022 Dec; 94(12):6091-6096. PubMed ID: 35940869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Hydroxychloroquine Use Is Not Significantly Associated with Positive PCR Results for SARS-CoV-2: A Nationwide Observational Study in South Korea.
    Bae S; Ghang B; Kim YJ; Lim JS; Yun SC; Kim YG; Lee SO; Kim SH
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33672785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxychloroquine for Prevention of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: Challenges to Trial Conduct During the Global Pandemic.
    Goldman JD
    Clin Infect Dis; 2021 Jun; 72(11):e844-e847. PubMed ID: 33159196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.